Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 373-376

  Mao, En Qiang ^a   Tang, Yao Qing ^a   Zhang, Sheng Dao ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; POLYSULFONE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD FLOW; BREATHING RATE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FILTER; FOLLOW UP; HEART RATE; HEMOFILTRATION; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MACHINE; MALE; PANCREAS NECROSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; STAGING; STATISTICAL ANALYSIS; STRATIFICATION; SURVIVAL RATE; THROMBOSIS; TREATMENT WITHDRAWAL; ULTRAFILTRATION;

EID: 0037442037     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.373     Document Type: Article

References (38)

1. Hartwig W, Maksan SM, Foitzik T, Schmidt J, Herfarth C, Klar E. Reduction in mortality with delayed surgical therapy of severe acute pancreatitis. J Gastrointest Surg 2002; 6: 481-487
2. Gebhardt C, Bodeker H, Blinzler L, Kraus D, Hergdt G. Changes in therapy of severe acute pancreatitis. Chirurg 1994; 65: 33-40
3. Yamauchi J, Takeda K, Shibuya K, Sunamura M, Matsuno S. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs. Pancreatology 2001; 1: 662-667
4. Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: What mediators should we block? Intensive Care Med 2002; 28: 139-146
5. Bank S, Singh P, Pooran N, Stark B. Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20 years. J Clin Gastroenterol 2002; 35: 50-60
6. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 175: 76-83
7. Van Laethem, Eskinazi R, Louis H, Richaert F, Bobberecht P, Deviere. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998; 43: 408-413
8. Hughes CB, Grewal HP, Gaber LW, Kotb M, Mohey El-Din AB, Mann L, Gaber AO. Anti-TNFα therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 1996; 171: 274-280
9. Hughes CB, Gaber LW, Mohey El-Din AB, Kotb M, Mann , Gaber AO. Inhibition of TNF improves survival in an experimental model of acute pancreatitis. Am Surg 1996; 62: 8-13
10. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997; 40: 1-4
11. Osman MO, Gesser B, Mortensen JT, Matsushima K, Jensen SL, Larsen CG. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 2002; 17: 53-59
12. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 2002; 6: 193-198
13. Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986; 13: 123-132
14. Gotloib L, Shostak A, Lev A, Fudin R, Jaichenko J. Treatment of surgical and non-surgical septic multiple organ failure with bicarbonate hemodialysis and sequential hemofiltration. Int Care Med 1995; 21: 104-111
15. Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1989; 17: 634-637
16. Gomez A, Wang R, Unruh H, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671-685
17. Mao EQ, Tang YQ, Han TQ, Yuan ZR, Zhang SD. Effects of short veno-venous hemofiltration on severe acute pancreatitis. Zhonghua Waike Zazhi 1999; 37: 141-143
18. Blinzler L, Hausßber J, Bodeker H, Zaune U, Martin E, Gebhardt C. Conservative treatment of severe necrotizing pancreatitis using early continuous veno-venous HF. In: Sieberth HG, Mann H, Stummvoll HK, eds. Continuous hemofiltration. Contrib Nephrol 1991; 93: 234-236
19. Yekebas EF, Treede H, Knoefel WT, Bloechle C, Fink E, Izbicki JR. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999; 229: 514-522
20. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis. Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590
21. Grewal HP, Mohey El Din A, Gaber L, Kotb M, Gaber O. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNFα polyclonal antibody. Am J Surg 1994; 167: 214-219
22. Tanaka N, Murata A, Uda K, Uda Ki, Toda H, Kato T, Hayashida H, Matsuura N, Mori T. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotic pancreatitis in a experimental model. Crit Care Med 1995; 23: 901-908
23. Denham W, Denham D, Yang J, Carter G, Mackay S, Moldawer LL, Carey LC, Norman J. Transient human gene therapy. A novel cytokine regulatory strategy for experimental pancreatitis. Ann Surg 1998; 227: 812-820
24. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-526
25. Schmidt J, Werner J. Acute pancreatitis: Reliable and prospective conservative therapy. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 434-438
26. Pupelis G, Austrums E, Snippe K. Blood purification methods for treatment of organ failure in patients with severe pancreatitis. Zentralbl Chir 2001; 126: 780-784
27. Miller BJ, Henderson A, Strong RW, Fielding GA, DiMarco AM, O'Loughlin BS. Necrotizing pancreatitis: Operating for life. World J Surg 1994; 18: 906-911
28. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997; 84: 920-935
29. Bone RC. Sir Isaac Newton, sepsis, sirs and cars. Crit Care Med 1996; 24: 1125-1127
30. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83: 919-923
31. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917-1922
32. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, Mcfadden DW. Interleukin-10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112: 960-967
33. Kusske AM, Rongione AJ, Ashley SW, Mcfadden DW, Reber HA. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996; 120: 284-289
34. Salomone T, Boni P, Serra C, Morselli-Labate AM, Di Gioia AL,Romboli M, Guariento A. The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis. Int J Pan 1996; 20: 197-203
35. Curley P, Nestor M, Collins K, Saporschetz I, Mendez M, Mannick JA, Rodrick M. Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology 1996; 110: 583-588
36. Kusske AM, Rongione AJ, Reber HA. Cytokine and acute pancreatitis. Gastroenterology, 1996; 110: 639-642
37. Discipio AW, Burchard KW. Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis. Am J Surg 1997; 173: 174-180
38. Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997; 113: 1966-1975